ProShare Advisors LLC - ARBUTUS BIOPHARMA CORP ownership

ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 55 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of ARBUTUS BIOPHARMA CORP
ValueSharesWeighting
Q3 2023$55,156
-11.1%
27,170
+0.7%
0.00%
Q2 2023$62,059
-15.4%
26,982
+11.4%
0.00%
Q1 2023$73,384
+14.3%
24,219
-12.1%
0.00%
Q4 2022$64,210
+36.6%
27,558
+12.4%
0.00%
Q3 2022$47,000
-26.6%
24,515
+3.4%
0.00%
Q2 2022$64,000
-31.2%
23,713
-23.7%
0.00%
Q1 2022$93,000
-34.5%
31,080
-15.1%
0.00%
Q4 2021$142,000
+5.2%
36,599
+16.3%
0.00%
Q3 2021$135,000
+18.4%
31,477
-16.2%
0.00%
Q2 2021$114,000
+192.3%
37,580
+219.8%
0.00%
Q1 2021$39,000
-17.0%
11,750
-10.3%
0.00%
Q4 2020$47,000
+104.3%
13,104
-14.9%
0.00%
Q3 2019$23,000
-45.2%
15,394
-24.3%
0.00%
Q2 2019$42,000
-48.1%
20,342
-10.3%
0.00%
Q1 2019$81,000
-5.8%
22,682
+0.7%
0.00%
-100.0%
Q4 2018$86,000
-66.1%
22,521
-16.3%
0.00%
-50.0%
Q3 2018$254,000
+25.1%
26,911
-3.3%
0.00%
+100.0%
Q2 2018$203,000
+59.8%
27,835
+9.4%
0.00%0.0%
Q1 2018$127,000
-15.3%
25,453
-14.2%
0.00%0.0%
Q4 2017$150,00029,6600.00%
Other shareholders
ARBUTUS BIOPHARMA CORP shareholders Q3 2019
NameSharesValueWeighting ↓
JACOB ASSET MANAGEMENT OF NEW YORK LLC 340,000$1,459,0000.53%
RTW INVESTMENTS, LP 4,733,323$20,306,0000.31%
APIS CAPITAL ADVISORS, LLC 70,000$300,0000.29%
Hudson Bay Capital Management LP 1,800,000$7,722,0000.10%
COWEN AND COMPANY, LLC 249,215$1,069,0000.05%
Kerrisdale Advisers, LLC 100,000$429,0000.05%
Woodline Partners LP 496,172$2,129,0000.04%
Shay Capital LLC 60,000$257,0000.03%
Walleye Capital LLC 231,037$991,0000.03%
BOOTHBAY FUND MANAGEMENT, LLC 212,700$912,0000.02%
View complete list of ARBUTUS BIOPHARMA CORP shareholders